RELAFEN 750 Pill - beige oval, 19mm
Generic Name: nabumetone
Pill with imprint RELAFEN 750 is Beige, Oval and has been identified as Relafen 750 mg. It is supplied by GlaxoSmithKline.
Relafen is used in the treatment of Osteoarthritis; Rheumatoid Arthritis and belongs to the drug class Nonsteroidal anti-inflammatory drugs. Risk cannot be ruled out during pregnancy. Relafen 750 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for RELAFEN 750
Relafen
- Generic Name
- nabumetone
- Imprint
- RELAFEN 750
- Strength
- 750 mg
- Color
- Beige
- Size
- 19.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Nonsteroidal anti-inflammatory drugs
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- GlaxoSmithKline
- National Drug Code (NDC)
- 00029-4852 (Discontinued)
More about Relafen (nabumetone)
- Check interactions
- Compare alternatives
- Reviews (38)
- Drug images
- Latest FDA alerts (4)
- Side effects
- Dosage information
- During pregnancy
- Drug class: Nonsteroidal anti-inflammatory drugs
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.